Publications by the researcher in collaboration with Gisela Feltes (25)

2024

  1. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

2023

  1. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  2. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  3. Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry

    Revista Portuguesa de Cardiologia, Vol. 42, Núm. 3, pp. 237-246

  4. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  5. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  6. Takotsubo Syndrome, Stressful Triggers, and Risk of Recurrence

    American Journal of Cardiology, Vol. 205, pp. 58-62

2022

  1. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022

  2. Erratum to “Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO” [Med Clin (Barc). 2020;155(12):521-528] (Medicina Clinica (2020) 155(12) (521–528), (S0025775320301895), (10.1016/j.medcli.2020.01.033))

    Medicina Clinica

  3. Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

    Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633

  2. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  3. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19

    Age and ageing, Vol. 50, Núm. 2, pp. 326-334

  4. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

    Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280

  5. Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis

    BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292

  6. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  7. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data

    Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324

  8. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

    American Heart Journal, Vol. 237, pp. 104-115

  9. Underlying heart diseases and acute covid-19 outcomes

    Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214